ConductScience.org, home

Paper7512751

Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Brooks PC and 2 others. Science, 1994. Cited by 2,578 papers, by iCite.

Cite this record

ConductScience Library. Requirement of vascular integrin alpha v beta 3 for angiogenesis. Papers, record 7512751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7512751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Requirement of vascular integrin alpha v beta 3 for angiogenesis.
PubMed
Journal
Science
PubMed
Year
1994
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
2,578
iCite
Relative citation ratio, by iCite
66.5
iCite
Revised in PubMed
2024-05-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Brooks PCP C
2Clark RAR A
3Cheresh DAD A

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Granulation TissueMajor topic
IntegrinsMajor topic
Neovascularization, PathologicMajor topic
Receptors, CytoadhesinMajor topic
Animals
Antibodies, Monoclonal
Blood Vessels
Chick Embryo
Fibroblast Growth Factor 2
Humans
Laminin
Melanoma
Receptors, Vitronectin
Skin
Tumor Necrosis Factor-alpha
von Willebrand Factor

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA45726NCI NIH HHSUnited StatesR01CA045726PubMed and NIHNIH RePORTER
CA50286NCI NIH HHSUnited StatesR01CA050286PubMed and NIHNIH RePORTER
R37CA050286NIHNIH RePORTER

Download CSV of grants

Trials3

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT01176500A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid TumorsBackgroundClinicalTrials.gov
NCT01633255[18]F-Fluciclatide for Kidney Cancer Imaging Studies and TreatmentBackgroundClinicalTrials.gov
NCT0487121768Ga-NODAGA-RGD PET in Patients With an Occluded Coronary ArteryBackgroundClinicalTrials.gov

Download CSV of trials

Cited by919

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,578 citations.

PMIDTitleJournalYearIn PapersSource
42900344The interplay of integrin, VE-cadherin, and β-catenin signaling triad in angiogenesis: regulation by Wnt antagonist, secreted frizzled related protein 4 in the tumor angiogenic loop.Med Oncol2026https://conductscience.org/library/papers/42900344PubMed
42757471Integrin αVβ3 as a context‑dependent regulator of bone homeostasis: Insights into osteoporosis pathogenesis and therapeutic targeting (Review).Mol Med Rep2026https://conductscience.org/library/papers/42757471PubMed
42592454Neutralizing dentin sialophosphoprotein facilitates tumor vascular normalization in colorectal cancer by blocking the crosstalk between tumor cells and endothelial cells.Acta Pharm Sin B2026https://conductscience.org/library/papers/42592454PubMed
42416355Breaking the vicious cycle of impaired angiogenesis and chronic inflammation in diabetic wounds: a bioengineered microneedle system delivering RGD-modified M2 exosomes.Burns Trauma2026https://conductscience.org/library/papers/42416355PubMed
42243842Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation.Mol Cancer2026https://conductscience.org/library/papers/42243842PubMed
42186350Application of Transgenic Silk Fibroin to Biomaterials.Biotechnol Bioeng2026https://conductscience.org/library/papers/42186350PubMed
42072707Galectin-3 Binds to the Allosteric Site and Activates Integrins αvβ3, αIIbβ3, and α5β1, and Lactose Inhibits This Activation.Biomolecules2026https://conductscience.org/library/papers/42072707PubMed
41961754Proteomic signatures of adipocyte recruitment in breast cancer.Endocr Relat Cancer2026https://conductscience.org/library/papers/41961754PubMed
41957669Oxidative stress induced by DMSA-IONPs impairs breast cancer cell migration and paracrine cell communication.J Nanobiotechnology2026https://conductscience.org/library/papers/41957669PubMed
41888978Reelin regulates the migration and differentiation of extravillous trophoblastic cells.Biol Res2026https://conductscience.org/library/papers/41888978PubMed
41849225The emerging role of integrin signaling in pulmonary vascular disease.Am J Physiol Lung Cell Mol Physiol2026https://conductscience.org/library/papers/41849225PubMed
41728292Acellular Adipose Tissue promotes anti-fibrotic remodeling in Phase II Study.medRxiv2026https://conductscience.org/library/papers/41728292PubMed
41676549Galectin-3 binds to the RGD-binding site in a glycan-independent manner and to the allosteric site and activates integrins αvβ3, αIIbβ3, and α5β1.bioRxiv2026https://conductscience.org/library/papers/41676549PubMed
41594872Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies.Biology (Basel)2026https://conductscience.org/library/papers/41594872PubMed
41530428Angiogenesis PET/MRI predicts initial growth of sporadic vestibular schwannomas: a prospective study with follow-up in 29 patients using [68Ga]Ga-NODAGA-E[c(RGDyK)]2.EJNMMI Res2026https://conductscience.org/library/papers/41530428PubMed
41401976Beyond transcription: RNA-binding proteins steering angiogenesis.Am J Physiol Heart Circ Physiol2026https://conductscience.org/library/papers/41401976PubMed
41141979Overexpression of αVβ3 Integrin in an Aortic Aneurysm Murine Model: Confirmation in Ex Vivo Human Abdominal Aortic Aneurysm Tissue and Its Potential Application for Molecular Imaging Characterisation.EJVES Vasc Forum2025https://conductscience.org/library/papers/41141979PubMed
41049616Lactylation-Boosted m5C RNA Modification Drives Choroidal Neovascularization.Research (Wash D C)2025https://conductscience.org/library/papers/41049616PubMed
41017463Intramyocardial Hydrogel Delivery Decreases Left Ventricular Remodeling and Increases Angiogenesis Post Myocardial Infarction.Circ Cardiovasc Imaging2025https://conductscience.org/library/papers/41017463PubMed
40961140Endothelial αvβ3 integrin induction during hypoxia protects blood-brain barrier integrity.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40961140PubMed

See all 919 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IGKV4-128908PubTator's text mininghttps://conductscience.org/library/genes/28908NCBI Gene
ITGAV3685PubTator's text mininghttps://conductscience.org/library/genes/3685NCBI Gene
TNF7124PubTator's text mininghttps://conductscience.org/library/genes/7124NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7512751

GET https://conductscience.org/api/papers/v1/7512751/cited_by?page=2